Supporting the relevance of NPC1 in breast cancer, a query of NPC1 in publicly available patient datasets demonstrated higher NPC1 mRNA in patients with basal, ER−, and high-grade tumors relative to ER+ low-grade disease (Figure 1G; Supplementary Figure S2A). Here, NPC1 is linked to breast cancer.